MENU
ASLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aslan Pharmaceuticals (ASLN) Ownership - Who owns Aslan Pharmaceuticals?

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
3 Temasek Avenue
Phone
+65 68179598
Employees
34
Web
https://www.aslanpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.7M
P/E Ratio
N/A
Total Cash
21.25M
Projected Growth
N/A
Total Debt
26.67M
Revenue
12M
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
7.51
Total Debt/Equity
N/A
Revenue/Share
5.51 USD as % of share price

Fundamentals

ASLN
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company which develops immuno-oncology agents and targeted therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Temasek Avenue
Phone
+65 68179598
Employees
34
Web
https://www.aslanpharma.com